You are here

FirstString Research, Inc

Company Information
Address
300 West Coleman Boulevard Suite 203
Mount Pleasant, SC 29464-5641
United States



Information

DUNS: 602545654

# of Employees: 12


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Improving marginal allograft outcomes through cell junction stabilization in transplantation

    Amount: $300,000.00

    Project Summary/Abstract: Transplantation is a highly successful therapy for end-stage renal disease but there is a significant shortage of available donor organs that has forced utilization of low-qu ...

    SBIRPhase I2020Department of Health and Human Services National Institutes of Health
  2. Evaluation of a Novel Therapeutic Approach to Treat Alcoholic Lung Syndrome

    Amount: $252,131.00

    PROJECT SUMMARY/ABSTRACT Twenty million people abuse alcohol in the United States and 1.8 million alcoholics are hospitalized every year. Alcoholic lung syndrome is recognized as a significant cause o ...

    SBIRPhase I2020Department of Health and Human Services National Institutes of Health
  3. Evaluation of a Novel Connexin-Based Peptide in the Treatment of Combined Ionizing Radiation and Thermal Burn Injury

    Amount: $300,000.00

    PROJECT SUMMARYThe threat of a nuclear attack or disaster resulting in mass casualties is of increasing concernRadiation injury frequently occurs in combination with thermal burnsCombined radiation an ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  4. Novel therapeutic approach in treatment of glioblastoma using sustained delivery of Connxin43 carboxy-terminal peptide encapsulated in biodegradable nanoparticles in combination with temozolomide

    Amount: $1,596,893.00

    PROJECT SUMMARY Glioblastoma (GBM) is an incurable cancer even with aggressive therapies such as surgical resection followed by radiotherapy and chemotherapy using temozolomide (TMZ). Efforts to impro ...

    SBIRPhase II2018Department of Health and Human Services National Institutes of Health
  5. A Novel Scaffold to Promote Skin Regeneration

    Amount: $225,000.00

    PROJECT SUMMARY Dermal scarring affects more than million people worldwide annually over million people are injured in motor vehicle accidents over million patients are severely burned ...

    STTRPhase I2017Department of Health and Human Services National Institutes of Health
  6. Evaluation of a Novel Connexin-Based Peptide for the Treatment of Diabetic Wounds

    Amount: $1,000,000.00

    Project SummaryAn estimatedmillion people worldwide have diabetesincluding overmillion AmericansA major cause of morbidity and hospitalization in patients with diabetes is diabetic foot ulcerationDFUw ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  7. Evaluation of a Connexin based Peptide for the Treatment of Age Related Macular Degeneration

    Amount: $225,000.00

    PROJECT SUMMARY ABSTRACT FirstString Research has identified a novel peptide that shows therapeutic potential in the treatment of age related macular degeneration AMD This Phase I SBIR will asses ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  8. A Novel Peptide-based Topical Therapeutic to Promote Corneal Regeneration and Restore Corneal Biomechanics Following Blast and Burn Injuries

    Amount: $999,961.00

    Ocular traumas resulting from explosive or incendiary devices are common battlefield injuries. Current therapeutics do not address the biological and molecular processes in corneal wound healing, and ...

    SBIRPhase II2017Department of Defense Defense Health Agency
  9. Stabilization of gap/tight junctions to ameliorate brain death induced endothelial cell injury

    Amount: $225,000.00

    DESCRIPTION provided by applicant Transplantation is a widely accepted and highly successful therapy for end stage heart disease While success rates and survival have risen steadily since its ince ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health
  10. A Novel Peptide-based Topical Therapeutic to Promote Corneal Regeneration and Restore Corneal Biomechanics Following Blast and Burn Injuries

    Amount: $99,862.00

    Ocular traumas resulting from explosive or incendiary devices are one of the most common injuries reported by our armed forces. Current standard of care protocols do not address the biological and mol ...

    SBIRPhase I2015Department of Defense Army
US Flag An Official Website of the United States Government